Level C· Early human research exploring benefitsProspective StudyEurope PMCOpen access

Efficacy of Fractional CO 2 Laser for Improvement of Limited Mouth Opening in Systemic Sclerosis

Bhat YJ., Bashir Y., Latif I., Daing A., Devi R., Shah IH.

Prospective Study on Systemic / IV, published in J Cutan Aesthet Surg (2022) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
J Cutan Aesthet Surg (2022)
Reported sample size
—
Source database
Europe PMC
PMID
37035592
PMCID
PMC10081469
DOI
10.4103/jcas.jcas_29_21
Citations
5

Abstract (original English)

Background Systemic sclerosis is a multisystem auto-inflammatory disease-causing fibrosis in the skin and internal organs. A frequent complication of systemic sclerosis is the limited mouth opening (LMO), a difficult-to-treat condition with only a few treatment options available. Aims and objectives The aim of this study was to evaluate the response of fractional carbon dioxide (CO 2 ) laser resurfacing in LMO associated with systemic sclerosis. Materials and methods This was a hospital-based prospective study in which diagnosed cases of systemic sclerosis were taken. Patients who had significant LMO and who gave informed consent were included in the study. Fractional CO 2 laser treatment was performed in the perioral area. Patients were assessed at baseline, after three and six sessions, and 3 months after the last session. Assessment was done by measurement of the interincisor distance (IID) using a ruler and calculation of the mouth handicap in systemic sclerosis (MHISS) scale. Results Improvement in IID occurred 3 months after the first session with a mean gain of +5 mm (range 2-7). At 6 months, a mean gain of +8.5 mm (range 7-10) in IID was observed ( P P Conclusion Fractional CO 2 laser forms a safe, effective, and well-tolerated treatment modality for improvement of LMO in systemic sclerosis. Limitations The limitations of this study were less number of patients and no l

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research